You searched for "ectropion"
Prism adaptation test in acquired non-accommodative esotropia
This study investigated factors related to the increase in prism adapted angle in patients with acquired non-accommodative comitant esotropia (ANAET) who had strabismus surgery based on the results of a short prism adaptation test (PAT) and evaluated their outcomes. Short...Clinical features of basic acquired nonaccommodative esotropia requiring surgery
Basic acquired nonaccommodative esotropia (BANAET) is a concomitant esotropia occurring after the age of six months without significant refractive error or accommodative element. Esotropia is similar for both near and distance and children have prior binocular single vision. The purpose...Closed-chamber haptic re-externalisation for posteriorly displaced sclerotomy and inadequate haptic tuck in glued posterior chamber intraocular lenses
This technique (online video http://jcrsjournal.org) emphasises the importance of both symmetrical and sufficient anterior placement of sclerotomies to externalise an adequate length of the haptics, which in turn provides good centration and stability of the intra-ocular lens (IOL). The authors...Two bifocals and a trifocal
The authors compare the optical outcomes of two bifocal intraocular lenses (AcrySof ReSTOR +2.50 Diopter [D] add +3.0D add) with a trifocal lens (AT LISA tri 839MP). The optical qualities of the lenses were quantified by measuring the modulation transfer...Effects of orbital decompression on duction, cyclotorsion and diplopia
This is a retrospective review of 156 patients (281 eyes / orbits) with Graves Orbitopathy (GO) who had orbital decompression (OD) between 2016 and 2020 from Amsterdam, Netherlands. Data analysis of type of OD, eye position, duction, cyclotorsion and level...Relating metamorphopsia severity and OCT findings in advanced epiretinal membranes
7 April 2021
| Kareem Waleed Alsaffarini
|
EYE - Vitreo-Retinal
The authors present the findings of a retrospective study to correlate metamorphopsia and ectopic inner foveal layers (EIFL) or ‘central bouquet’ abnormality (CBA) in patients with advanced stages of epiretinal membrane (ERM) following the new OCT‐based grading scheme as described...
Management and outcomes of congenital fibrovascular pupillary membranes (CFPM)
Congenital fibrovascular pupillary membranes (CFPM) is defined as a white fibrous membrane across the pupil which may be an ectopic iris tissue arising from the aberrant migration of neural crest cells or a variant of persistent fetal vasculature. The authors...Brolucizumab in age-related macular degeneration, HAWK Study
3 October 2023
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Neovascular age-related macular degeneration, aflibercept, anti-vascular endothelial growth factor therapy, brolucizumab, commercial formulation
The aim of the study was to collect additional data on efficacy and safety of brolucizumab 6mg intended for commercialization in age-related macular degeneration (AMD) (with an increase in pH and decrease in polysorbate concentration). The HAWK Study was a...
Eye News Bring Artistic Eye to RCOphth
29 April 2022
Eye News is delighted to be taking some of Steve Thomson's artwork to the RCOphth in May, raising money for the charity Fight for Sight.
Subthreshold micropulse laser treatment in chronic central serous chorioretinopathy
1 February 2016
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This retrospective study was conducted to assess the treatment of 38 patients of chronic central serous chorioretinopathy with a 577-nm subthreshold micropulse laser (SML) Supra Scan Quantel Medical. Eighteen patients of these had persistent subretinal fluid (SRF) after photodynamic therapy....
Post hoc analysis of the CANTREAT randomised trial
1 December 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Age-related macular degeneration, Randomized clinical trial, Ranibizumab, Treat-and-extend
CANTREAT, a Canadian multicentre two-year randomised trial compares treat and extend treatment (T&E) relative to the monthly administration of Ranibizumab in nAMD. Two-hundred and eighty-five treatment-naïve patients with nAMD were randomised to receive either a once-monthly dosing or T&E regimen...
Chrome extensions
1 June 2019
| David Haider
Chrome is the most popular internet browser, with 44% of the market share (April ‘19). The other browsers of relevance are: Safari (31%) and Firefox (14%). Both Chrome and Firefox can be used on PC and Mac. Safari is only...